Tags

Type your tag names separated by a space and hit enter

[Sclerosing peritonitis and practolol (author's transl)].

Abstract

Skin manifestations, eye complications, a nephrotic syndrome, appearance of lupus erythematosus cells and antinuclear antibodies, sometimes combined with a systemic side effects of the beta adrenergic blocker Practolol. Another side effect is though to be sclerosing peritonitis. The latter is identical with the idiopathic fibroplastic peritonitis, described at the turn of this fibroplastic peritonitis, described at the turn of this century by German authors. Our own observation of a case of sclerosing peritonitis is compared with the literature. There is strong evidence for a causal relationship between longstanding Practolol-therapy and sclerosing peritonitis. Practolol was withdrawn from the market in 1975.

Links

Authors

,

Source

Medizinische Klinik 72:28-29 1977 Jul 15 pg 1220-4

MeSH

Aged
Angina Pectoris
Female
Humans
Peritonitis
Practolol
Sclerosis
Time Factors

Pub Type(s)

Case Reports
English Abstract
Journal Article

Language

ger

PubMed ID

887049

Citation

Hess, T, and P Stucki. "[Sclerosing Peritonitis and Practolol (author's Transl)]." Medizinische Klinik, vol. 72, no. 28-29, 1977, pp. 1220-4.
Hess T, Stucki P. [Sclerosing peritonitis and practolol (author's transl)]. Med Klin. 1977;72(28-29):1220-4.
Hess, T., & Stucki, P. (1977). [Sclerosing peritonitis and practolol (author's transl)]. Medizinische Klinik, 72(28-29), pp. 1220-4.
Hess T, Stucki P. [Sclerosing Peritonitis and Practolol (author's Transl)]. Med Klin. 1977 Jul 15;72(28-29):1220-4. PubMed PMID: 887049.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Sclerosing peritonitis and practolol (author's transl)]. AU - Hess,T, AU - Stucki,P, PY - 1977/7/15/pubmed PY - 2000/3/22/medline PY - 1977/7/15/entrez SP - 1220 EP - 4 JF - Medizinische Klinik JO - Med Klin VL - 72 IS - 28-29 N2 - Skin manifestations, eye complications, a nephrotic syndrome, appearance of lupus erythematosus cells and antinuclear antibodies, sometimes combined with a systemic side effects of the beta adrenergic blocker Practolol. Another side effect is though to be sclerosing peritonitis. The latter is identical with the idiopathic fibroplastic peritonitis, described at the turn of this fibroplastic peritonitis, described at the turn of this century by German authors. Our own observation of a case of sclerosing peritonitis is compared with the literature. There is strong evidence for a causal relationship between longstanding Practolol-therapy and sclerosing peritonitis. Practolol was withdrawn from the market in 1975. SN - 0025-8458 UR - https://www.unboundmedicine.com/medline/citation/887049/[Sclerosing_peritonitis_and_practolol__author's_transl_]_ DB - PRIME DP - Unbound Medicine ER -